The Philippine FDA has approved the emergency use of AstraZeneca PLC’s COVID-19 vaccine.
The Philippines has signed deals to buy 17 million doses of AstraZeneca’s vaccine, including a private sector agreement for 2.6 million doses in November.
With more than 518,000 COVID-19 cases and nearly 10,500 deaths, the Philippines has the second-highest case load in Southeast Asia, after Indonesia.